Copyright Reports & Markets. All rights reserved.

Global and Japan NK Cells Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 NK Cells Product Introduction
  • 1.2 Market Segments
  • 1.3 Key NK Cells Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global NK Cells Market Size Growth Rate by Type
    • 1.4.2 Mogamulizumab
    • 1.4.3 Lorvotuzumab Mertansine
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global NK Cells Market Size Growth Rate by Application
    • 1.5.2 Cancer
    • 1.5.3 Cardiovascular Diseases
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global NK Cells Market Size, Estimates and Forecasts
    • 2.1.1 Global NK Cells Revenue 2015-2026
    • 2.1.2 Global NK Cells Sales 2015-2026
  • 2.2 Global NK Cells, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 NK Cells Historical Market Size by Region (2015-2020)
    • 2.3.1 Global NK Cells Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global NK Cells Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 NK Cells Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global NK Cells Sales Forecast by Region (2021-2026)
    • 2.4.2 Global NK Cells Revenue Forecast by Region (2021-2026)

3 Global NK Cells Competitor Landscape by Players

  • 3.1 Global Top NK Cells Sales by Manufacturers
    • 3.1.1 Global NK Cells Sales by Manufacturers (2015-2020)
    • 3.1.2 Global NK Cells Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global NK Cells Manufacturers by Revenue
    • 3.2.1 Global NK Cells Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global NK Cells Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global NK Cells Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by NK Cells Revenue in 2019
    • 3.2.5 Global NK Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global NK Cells Price by Manufacturers
  • 3.4 Global NK Cells Manufacturing Base Distribution, Product Types
    • 3.4.1 NK Cells Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers NK Cells Product Type
    • 3.4.3 Date of International Manufacturers Enter into NK Cells Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global NK Cells Market Size by Type (2015-2020)
    • 4.1.1 Global NK Cells Sales by Type (2015-2020)
    • 4.1.2 Global NK Cells Revenue by Type (2015-2020)
    • 4.1.3 NK Cells Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global NK Cells Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global NK Cells Sales Forecast by Type (2021-2026)
    • 4.2.2 Global NK Cells Revenue Forecast by Type (2021-2026)
    • 4.2.3 NK Cells Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global NK Cells Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global NK Cells Market Size by Application (2015-2020)
    • 5.1.1 Global NK Cells Sales by Application (2015-2020)
    • 5.1.2 Global NK Cells Revenue by Application (2015-2020)
    • 5.1.3 NK Cells Price by Application (2015-2020)
  • 5.2 NK Cells Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global NK Cells Sales Forecast by Application (2021-2026)
    • 5.2.2 Global NK Cells Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global NK Cells Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan NK Cells Market Size YoY Growth 2015-2026
    • 6.1.1 Japan NK Cells Sales YoY Growth 2015-2026
    • 6.1.2 Japan NK Cells Revenue YoY Growth 2015-2026
    • 6.1.3 Japan NK Cells Market Share in Global Market 2015-2026
  • 6.2 Japan NK Cells Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top NK Cells Players by Sales (2015-2020)
    • 6.2.2 Japan Top NK Cells Players by Revenue (2015-2020)
  • 6.3 Japan NK Cells Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan NK Cells Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan NK Cells Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan NK Cells Price by Type (2015-2020)
  • 6.4 Japan NK Cells Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan NK Cells Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan NK Cells Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan NK Cells Price Forecast by Type (2021-2026)
  • 6.5 Japan NK Cells Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan NK Cells Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan NK Cells Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan NK Cells Price by Application (2015-2020)
  • 6.6 Japan NK Cells Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan NK Cells Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan NK Cells Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan NK Cells Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America NK Cells Market Size YoY Growth 2015-2026
  • 7.2 North America NK Cells Market Facts & Figures by Country
    • 7.2.1 North America NK Cells Sales by Country (2015-2020)
    • 7.2.2 North America NK Cells Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe NK Cells Market Size YoY Growth 2015-2026
  • 8.2 Europe NK Cells Market Facts & Figures by Country
    • 8.2.1 Europe NK Cells Sales by Country
    • 8.2.2 Europe NK Cells Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific NK Cells Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific NK Cells Market Facts & Figures by Country
    • 9.2.1 Asia Pacific NK Cells Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific NK Cells Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America NK Cells Market Size YoY Growth 2015-2026
  • 10.2 Latin America NK Cells Market Facts & Figures by Country
    • 10.2.1 Latin America NK Cells Sales by Country
    • 10.2.2 Latin America NK Cells Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa NK Cells Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa NK Cells Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa NK Cells Sales by Country
    • 11.2.2 Middle East and Africa NK Cells Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Chipscreen Biosciences (China)
    • 12.1.1 Chipscreen Biosciences (China) Corporation Information
    • 12.1.2 Chipscreen Biosciences (China) Description and Business Overview
    • 12.1.3 Chipscreen Biosciences (China) Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Chipscreen Biosciences (China) NK Cells Products Offered
    • 12.1.5 Chipscreen Biosciences (China) Recent Development
  • 12.2 Affimed NV (Netherlands)
    • 12.2.1 Affimed NV (Netherlands) Corporation Information
    • 12.2.2 Affimed NV (Netherlands) Description and Business Overview
    • 12.2.3 Affimed NV (Netherlands) Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Affimed NV (Netherlands) NK Cells Products Offered
    • 12.2.5 Affimed NV (Netherlands) Recent Development
  • 12.3 Altor BioScience Corporation (USA)
    • 12.3.1 Altor BioScience Corporation (USA) Corporation Information
    • 12.3.2 Altor BioScience Corporation (USA) Description and Business Overview
    • 12.3.3 Altor BioScience Corporation (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Altor BioScience Corporation (USA) NK Cells Products Offered
    • 12.3.5 Altor BioScience Corporation (USA) Recent Development
  • 12.4 Innate Pharma SA (France)
    • 12.4.1 Innate Pharma SA (France) Corporation Information
    • 12.4.2 Innate Pharma SA (France) Description and Business Overview
    • 12.4.3 Innate Pharma SA (France) Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Innate Pharma SA (France) NK Cells Products Offered
    • 12.4.5 Innate Pharma SA (France) Recent Development
  • 12.5 Takeda Pharmaceutical (Japan)
    • 12.5.1 Takeda Pharmaceutical (Japan) Corporation Information
    • 12.5.2 Takeda Pharmaceutical (Japan) Description and Business Overview
    • 12.5.3 Takeda Pharmaceutical (Japan) Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Takeda Pharmaceutical (Japan) NK Cells Products Offered
    • 12.5.5 Takeda Pharmaceutical (Japan) Recent Development
  • 12.6 Sorrento Therapeutics Inc. (USA)
    • 12.6.1 Sorrento Therapeutics Inc. (USA) Corporation Information
    • 12.6.2 Sorrento Therapeutics Inc. (USA) Description and Business Overview
    • 12.6.3 Sorrento Therapeutics Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Sorrento Therapeutics Inc. (USA) NK Cells Products Offered
    • 12.6.5 Sorrento Therapeutics Inc. (USA) Recent Development
  • 12.7 NantKwest Inc. (USA)
    • 12.7.1 NantKwest Inc. (USA) Corporation Information
    • 12.7.2 NantKwest Inc. (USA) Description and Business Overview
    • 12.7.3 NantKwest Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 NantKwest Inc. (USA) NK Cells Products Offered
    • 12.7.5 NantKwest Inc. (USA) Recent Development
  • 12.8 Bristol-Myers Squibb (USA)
    • 12.8.1 Bristol-Myers Squibb (USA) Corporation Information
    • 12.8.2 Bristol-Myers Squibb (USA) Description and Business Overview
    • 12.8.3 Bristol-Myers Squibb (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Bristol-Myers Squibb (USA) NK Cells Products Offered
    • 12.8.5 Bristol-Myers Squibb (USA) Recent Development
  • 12.9 NKT Therapeutics (USA)
    • 12.9.1 NKT Therapeutics (USA) Corporation Information
    • 12.9.2 NKT Therapeutics (USA) Description and Business Overview
    • 12.9.3 NKT Therapeutics (USA) Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 NKT Therapeutics (USA) NK Cells Products Offered
    • 12.9.5 NKT Therapeutics (USA) Recent Development
  • 12.11 Chipscreen Biosciences (China)
    • 12.11.1 Chipscreen Biosciences (China) Corporation Information
    • 12.11.2 Chipscreen Biosciences (China) Description and Business Overview
    • 12.11.3 Chipscreen Biosciences (China) Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Chipscreen Biosciences (China) NK Cells Products Offered
    • 12.11.5 Chipscreen Biosciences (China) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key NK Cells Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 NK Cells Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    NK Cells market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global NK Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the NK Cells market is segmented into
    Mogamulizumab
    Lorvotuzumab Mertansine
    Others

    Segment by Application, the NK Cells market is segmented into
    Cancer
    Cardiovascular Diseases
    Others

    Regional and Country-level Analysis
    The NK Cells market is analysed and market size information is provided by regions (countries).
    The key regions covered in the NK Cells market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and NK Cells Market Share Analysis
    NK Cells market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in NK Cells business, the date to enter into the NK Cells market, NK Cells product introduction, recent developments, etc.
    The major vendors covered:
    Chipscreen Biosciences (China)
    Affimed NV (Netherlands)
    Altor BioScience Corporation (USA)
    Innate Pharma SA (France)
    Takeda Pharmaceutical (Japan)
    Sorrento Therapeutics Inc. (USA)
    NantKwest Inc. (USA)
    Bristol-Myers Squibb (USA)
    NKT Therapeutics (USA)

    Buy now